Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Orders ship within 24 hours in discreet, unmarked packaging
Great customer service
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
There is no established tolerable upper intake level (UL), so even high-dose injections are safe because your system simply eliminates what it cannot use
US$ 22.15
US$ 24.40
US$ 26.38
US$ 24.52
US$ 23.26
